Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Vinorelbine|DRUG: Trastuzumab Emtansine
Sponsor: University of Miami
Collaborators: Genentech, Inc.